Abstract Despite advances in surgery, chemotherapy and radiotherapy, the outcomes of patients with GBM have not significantly improved. Tumor recurrence in the resection margins occurs in more than 80 % of cases indicating aggressive treatment modalities, such as gene therapy are warranted. We have examined photochemical internalization (PCI) as a method for the non-viral transfection of the cytosine deaminase (CD) suicide gene into glioma cells. The CD gene encodes an enzyme that can convert the nontoxic antifungal agent, 5-fluorocytosine, into the chemotherapeutic drug, 5-fluorouracil. Multicell tumor spheroids derived from established rat and human glioma cell lines were used as in vitro tumor models. Plasmids containing either the CD gene alone or together with the uracil phosphoribosyl transferase (UPRT) gene combined with the gene carrier protamine sulfate were employed in all experiments.PCI was performed with the photosensitizer AlPcS 2a and 670 nm laser irradiance. Protamine sulfate/CD DNA polyplexes proved nontoxic but inefficient transfection agents due to endosomal entrapment. In contrast, PCI mediated CD gene transfection resulted in a significant inhibition of spheroid growth in the presence of, but not in the absence of, 5-FC. Repetitive PCI induced transfection was more efficient at low CD plasmid concentration than single treatment. The results clearly indicate that AlPcS 2a -mediated PCI can be used to enhance transfection of a tumor suicide gene such as CD, in malignant glioma cells and cells transfected with both the CD and UPRT genes had a pronounced bystander effect.
Introduction
Despite substantial improvements in imaging and treatment consisting of surgery, radiation therapy and chemotherapy, the survival of patients diagnosed with glioblastoma multiforma (GBM) has not improved significantly over the past four decades, remaining at approximately 12-14 months [1, 2] . Even with MRI-defined gross surgical resection of the main tumor mass, tumor recurrence in the resection margins occurs in more than 80 % of cases [3] . Additionally, gliomas almost never metastasize to other regions outside the CNS. More aggressive intracavity post-operative treatment modalities, such as gene therapy therefore seems warranted. Among several cancer gene therapy approaches currently being developed, are insertion of wild type genes to correct primary genetic defects, and suicide gene therapy. The latter involves transfection into tumor cells of nonmammalian genes encoding enzymes that convert nontoxic pro-drugs into toxic metabolites capable of inhibiting nucleic acid synthesis [4] [5] [6] . In particular, suicide gene therapy utilizing the induction of cytosine deaminase (CD), an enzyme which converts the antifungal agent 5-fluorocytosine (5-FC) into its antimetabolite 5-fluorouracil (5-FU) has been previously studied for glioma [7] [8] [9] [10] . Gene-directed enzyme prodrug therapy activating strategies are of interest since a high concentration of toxic drug is produced mainly at the tumor site significantly reducing the side effects caused by systemic drug administration. In addition the bystander effect, where activated drug is exported from the transfected cancer cells into the tumor microenvironment, plays an important role by inhibiting growth of adjacent tumor cells.
In order for DNA to enter cells, some form of gene carrier either viral or nonviral is required. Although recombinant viral vectors are more efficient than their nonviral counterparts, they also present some considerable disadvantages such as undesired immune responses particularly upon repeated administrations, safety concerns and issues relating to bulk production and quality control. Additionally viral vectors have varying transfection efficiency dependent on target cell type which might make their effects in patients difficult to predict [11, 12] .
Nonviral vectors are therefore an interesting alternative. Polyamine gene carriers, such as protamine sulfate (PrS), have low toxcicity, form stable PrS/DNA polyplexes, and are readily taken up by cells via endocytosis. Unfortunately they usually demonstrate low transfection efficiency due to limited endosomal escape [13, 14] .
The problem of endosomal entrapment can be circumvented by the technique of photochemical internalization (PCI) [15] [16] [17] . PCI is a technique which utilizes the photochemical properties of photodynamic therapy (PDT) for the enhanced delivery of macromolecules like plasmid DNA and its associated gene carrier into the cell cytoplasm. Macromolecules that are internalized into cells via endocytosis end up inside and trapped in the intracellular endosomes and lysosomes. The concept of PCI is based on using photo sensitizers which localize in the cell membrane. Since endosome membranes are formed from the cell membrane they will also contain photosensitizer which will be transported into the cell during the endocytotic event. The macromolecule is therefore inside the endosome lumen while the photosensitizer is in the membrane. When light is applied, the photo sensitizer will react with oxygen causing endocytic membrane rupture releasing the trapped macromolecules into the cell cytosol, avoiding lysosomal degradation. This is illustrated in Fig. 1a . The released gene can therefore exert its full biological activity, in contrast to being degraded by lysosomal hydrolases (Fig. 1b) . PCI has been demonstrated with nonviral gene carriers to increase gene transfection of wild type suppressor genes such as P53 and PTEN into cells containing mutated or absent genes [18] [19] [20] . PCI has also demonstrated an enhanced transfection rate employing the herpes simplex virus thymidine kinase gene, increasing the cytotoxicity of ganciclovir to glioma cells [21] . To our knowledge use of this targeting technique has not been used to enhance the insertion of the CD gene into tumor cells. The aim of the present research was designed to evaluate the effects of 5-FC following PCI mediated PrS-CD gene transfection on multicell glioma spheroids from two different glioma cell lines. Tumor spheroids mimic in vivo tumors in their micro-environment in terms of gene expression, oxygen gradient characteristic and the biological behavior of the cells and are well suited to this type of in vitro study since they represent a bridge between monolayer cultures and in vivo animal experiments. [22] .
Materials and methods

Cell lines and plasmids
Cell lines
The human U87 and rat F98 glioma cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). The tumor cells were grown as monolayers in Advanced DMEM medium (Invitrogen Corp., Carlsbad CA., Cat. # 35101) with 2 % heat-inactivated fetal bovine serum (FBS), at 37°C and 5 % CO2. The plasmid coding for the CD gene, used in the PCI mediated transfection experiments, was purchased from Add gene (Cambridge, MA). The plasmids were transformed in E. coli strain of DH5alpha and isolated with QIAGEN according to the manufacture's instruction. Plasmid DNA concentrations were measured with a spectrophotometer (Nanodrop 1000 Therma Scientific).
Polyamine gene carrier, protamine sulfate (PrS)
Protamine sulfate/DNA polyplexes were formed as previously described [20] . An N/P ratio of the PS/DNA polyplexes of 10:1 was used in all experiments.
Toxcicity of 5-FC and 5-FU
The direct effect of the prodrug 5-FC and the drug 5-FU on glioma cell viability was first assayed in monolayers of the cell lines. For this, 8 wells (in 96-well flat bottomed plates) for each concentration of the drugs used were seeded with F98 or U87 cells at a density of 5,000 cells per well and incubated for 24 h prior to experimentation. Following exposure to 5-FC or 5-FU, incubation was continued for 48 h, at which point the culture medium was replaced with fresh clear buffer containing MTS reagents (Promega, Madison, WI) and incubated for a further 2 h. The optical density was read using an ELx800uv Universal Microplate Reader (BIO-TEK Instruments, Inc).
PCI mediated gene transfection
Both cell monolayers and multi tumor cell spheroids were transfected in a similar manner. Spheroids were formed by a modification of the centrifugation method [23, 24] . Briefly, 2.5 9 10 3 U87 or F98 cells in 200 ll of culture medium were alloquated into the wells of ultra-low attachment surface 96-well round-bottomed plates (Corning Inc., NY). The plates were centrifuged at 1,000 rpm for 30 min. Spheroids were formed in every fourth column of 8 wells in the plate. 1 lg/ml of the photosensitizer AlPcS 2a and the PrS/CD DNA polyplexes were added to the cell cultures and incubated for 18 h. Following a triple wash the monolayers or spheroids were incubated for 4 h in fresh medium to allow some of the photosensitizer to leach from the cell membrane in order to reduce the PDT toxic effects on the cells. Light treatment at various radiant exposures at an irradiance of 5 mW/cm 2 was administered with k = 670 nm light from a diode laser (Intense; New Jersey USA). Typically, 8-16 spheroids were followed in 3 individual trials for up to twenty-one days of incubation. Culture medium in the wells was exchanged every third day. Determination of spheroid size was carried out by averaging two measured perpendicular diameters of each spheroid using a microscope with a calibrated eyepiece micrometer and their volume calculated assuming a perfect sphere.
PCI transfection efficiency of the CD gene by fluorescent labeled antibody 5 9 10 4 F98 or U87 cells were plated out in 35 mm imaging dishes and incubated for 24 h. PCI mediated CD gene transfection was performed as previously described. Forty-eight hours later the monolayers were given a triple wash with HBSS (?) and Methanol fixation. The monolayers were incubated overnight at 4°C with sheep polyclonal anti CD antibody (Abcam, Cambridge, MA. Cat. # ab35251). The dishes were washed twice and incubated for 1 h with Alexa Fluor 488 Donkey Anti Sheep antibody (Life Technology, Grand Island, NY, Cat. # A11015). Detection was done using an inverted Zeiss laser-scanning microscope (LSM 410, Carl Zeiss, Jena, Germany). The 
Generation of stable CD gene positive cell lines
Astable F98 cell line expressing both the CD and uracil phosphoribosyl transferase (UPRT) genes was cloned (designated CD1), using a fusion plasmid pSELECT-zeoFcy::fur, (InvivoGenSan Diego, CA. Cat # psrtz-fcyfur). This plasmid has combined the gene encoding uracil phosphoribosyl transferase (UPRT) to the CD gene [25, 26] .Cells positive for the CD gene were selected following iterative Zeocin treatment. Parental F98 cells gradually were eliminated over a 3 weeks period. Confirmation of the CD gene was done by fluorescent antibody staining and sensitivity to 5-FC (MTS).
Statistics
Microsoft Excel was employed for the calculation of the arithmetic mean, standard deviation, and standard error. Experimental data were analyzed using one-way analysis of variance (ANOVA) at the significance level of p \ 0.05 and presented as mean with standard error unless otherwise noted.
Results
Direct toxicity on monolayers
The effects of 5-FC and 5-FU were examined on monolayers of F98 and U87 cells in the MTS cytotoxicity assay.
As shown in 
Spheroid growth inhibition by 5-FC following PCI-CD gene insertion
The effects 5-FC on the growth and development of spheroids following PCI CD gene transfection is shown Figure 3c shows the average spheroid volume as a percentage of PDT controls, measured after a 3-week period. Three identical experiments were performed with 16 spheroids in each group per experiment. As can be seen from Fig. 3c , PCI transfection of the CD gene in the absence of 5-FC had only a slight effect on spheroid growth, with no significant differences between the PDT control and the cultures containing the PrS-CD polyplexes at all the CD DNA concentrations tested. In contrast the addition of 5-FC for both F98 and U87 cells caused a significant growth inhibition (p \ 0.05), that was dependent on the CD gene concentration employed for gene transfection. The differences between the two cell lines was not significant (p [ 0.1) at all of the CD-DNA concentrations tested.
Growth inhibition by repetitive treatment
Since the effects of PCI-CD gene transfection were not pronounced at low CD DNA concentrations (1-2 lg/ml) repetitive treatment protocols were examined. The spheroids were transfected with either 1 or 2 complete PCI cycles 2 and 5 days following spheroid generation. 50 lM of 5-FC was added after light treatment in each case. Spheroid growth was followed in all for a period of 3 weeks. As seen in the low power micrograph taken after 2 weeks in culture (Fig. 4a) , a second PCI mediated CD gene transfection and 5-FC dose significantly inhibited spheroid growth compared to single treatment. The kinetics of the growth of CD transfected spheroids following single and double treatment is shown in Fig. 4b and c for F98 and U87 respectively. Single treatment with 2 lg/ml CD DNA induced a growth delay but by week 3 spheroid volume was comparable to controls. In contrast, repetitive treatment for both cell types, especially at CD DNA concentration of 4 lg/ml, had a significant inhibitory effect (p \ 0.05) compared to PDT controls.
Analysis of the bystander effect
The CD1 cell line could be show by fluorescent labeled antibody to be 100 % CD positive (Fig. 5a ). To determine the by stander effect, hybrid spheroids were generated containing varying ratios of CD positive (CD1) and CD negative native F98 cells. Each spheroid initially containing a total of 5 9 10 3 cells per well. 50 lM of 5-FC was added 24 h following spheroid generation to the experimental wells. 5-FC had a dramatic effect on the CD1 as well as the hybrid spheroids at all the F98:CD1 ratios tested. As shown in the photomicrographs (Fig. 5b) , by week 3 of culture, spheroids containing only CD1 cells were completely disrupted and contained no viable cells. This was also the case for spheroids containing F98:CD1 ratios of 1:1, 2:1 and 4:1 where, by week 3, the spheroids had disintegrated (data not shown).Spheroids containing F98:CD1 ratios of 10:1 maintained their original (day 1) size and shape but did not disintegrate. Since by week 3 many of the spheroids had completely lost their initial shape the spheroid volume was assayed following only 2 weeks in culture. At all of the F98:CD1 ratios examined the spheroids showed no growth but remained at their initial volume (Fig. 5c ). By week 3 many of the spheroids had disintegrated, in a similar pattern as seen in Fig. 5b , for CD1 spheroids. 
Discussion
The ability to enhance the nonviral insertion of functioning prodrug activating genes into glioma cells by PCI formed the basis of the study presented here. The aim of PCI, in a more general context, would be the site-specific transfection of tumor cells limited to the nests of tumor cells sequestered in the margins of the resection cavity following surgical removal of bulk tumor, while minimizing a more wide spread damage to surrounding brain tissue. The rapid attenuation of light in the brain limits the efficacy of PCI to the light irradiated area.
Among the most studied suicide gene therapy approaches, activation of ganciclovir (GCV) by herpes simplex virusthymidine kinase (HSV-TK) and activation of 5-FC by the CD gene have been and are now presently being tested in clinical trials for glioma treatment [27] .
For treatment of brain tumors it is important that the pro-drug can pass the blood brain barrier. 5-FC is a small molecule with relatively low protein binding and penetrates into cerebrospinal fluid (CSF). CSF concentrations of 5-FC have been shown to obtain about 75 % of serum concentration [28] . 5-FC has been used routinely for many years and has a high oral bio-availability of 80 % [29] compared to GCV's 6 % [30] . Additionally, the penetration of GCV into CSF and the brain is very low [31] .Moreover, serious side effects are not encountered when serum concentrations of 5-FC do not exceed 770 lM [32] . The results of the experiments presented here could demonstrate that PCI mediated non viral gene transfection, using protamine as gene carrier, significantly enhanced the effects of 5-FC on multi cell glioma spheroids derived from both rat and human cell lines. In a previous study, protamine/DNA polyplexes demonstrated a dramatic increase in transfection rate for the reporter GFP gene following PCI [20] . Transfection rates of 30-40 % were obtained and this agrees well with the results shown in Fig 3b. In particular, the observation that repeated PCI CD gene transfection (Fig. 4) was more efficient than single treatment is of importance. The low toxicity of a gene carrier like PrS, compared to polyethylenimine, would allow PCI iterative therapy and would therefore constitute a considerable advantage. The option of repetitive treatment protocols are severely limited if viral transfection vectors are employed owing to undesired immune responses to the viral carrier.
One of the advantages 5-FC CD therapy has over other forms of gene therapy is the pronounced bystander effect, especially if combined with the UPRT gene, as is the case for the CD1 cell line. Co-expression of CD and UPRT has been shown to increase the toxic effect of 5-FC by 1-3 orders of magnitude over treatment with CD/5-FC alone and provides a greater bystander effect [33] [34] [35] .
Even 10 % of CD1 cells incorporated into hybrid F98 spheroids could completely stop their growth (Fig. 5c ). This would indicate that a transfection efficiency of only 10 %, well below the 30-40 % PCI transfection rate observed employing immune fluorescence (fig 3b) , is sufficient to inhibit tumor progression. For this reason we did not titrate the F98:CD1 cell ratio beyond the 10:1 level.
Although it is difficult to translate in vitro results into clinical expectations, PCI has the potential to increase nonviral gene transfection rates to those obtained with viral vectors and in a site specific manner. From a clinical point of view, in patients undergoing cyto reductive surgery, light could be applied via an indwelling balloon applicator implanted in the resection cavity [36] [37] [38] . CD gene transfection and subsequent bystander cytotoxicity would therefore be limited to the walls of the cavity where tumor recurrences usually form. This would also allow repetitive treatment protocols. In addition to the PDT effect on the endosomal membrane (PCI effect), PDT also has a direct effect on the vasculature in the vicinity of the illuminated volume. PDT has been shown to open the blood brain barrier both to drugs and to cells carrying magnetic nanoparticles [39, 40] . This effect can prove advantageous by increasing delivery of gene carrying nanoparticles that can protect the gene-carrying polyplex during circulation, allowing for systemic injection and cellular internalization. [41] . In vivo studies in a rat glioma model, employing this type of nanoparticle in combination with PCI as a non viral delivery system for the CD gene, are now in progress.
